Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.61 USD
Change Today -0.006 / -0.98%
Volume 283.8K
RNN On Other Exchanges
As of 8:04 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Rakesh Soni

President and Chief Operating Officer, Rexahn Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2014


Mr. Rakesh Soni, also known as Rick, has been the President and Chief Operating Officer of Rexahn Pharmaceuticals, Inc. since August 10, 2009. Mr. Soni served as Chief Business Officer of Rexahn Pharmaceuticals, Inc. from July 2008 to August 10, 2009. He joined Rexahn in 2008. He has over 20 years of sales, marketing, product planning and business development experience in the pharmaceutical industry. Prior to Rexahn, he held several leadership roles at Otsuka America ...

Read Full Background

Corporate Headquarters*

15245 Shady Grove Road
Rockville, Maryland 20850

United States

Phone: 240-268-5300
Fax: 240-268-5310

Board Members Memberships*

There is no Board Members Memberships data available.


University of Wisconsin - Madison
Fairleigh Dickinson University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$250,000

Stock Options*

All Other Compensation$12,347
Exercisable Options565,000
Unexercisable Options120,000
Total Number of Options685,000

Total Compensation*

Total Annual Cash Compensation$262,347
Total Short Term Compensation$250,000
Other Long Term Compensation$12,347
Total Calculated Compensation$331,253
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RNN:US $0.61 USD -0.006


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REXAHN PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at